The FDA issued a warning letter to Metuchen over print and Internet ads that misrepresented Stendra's risk information and indication. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
